AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Carasent

Earnings Release Aug 21, 2019

3568_rns_2019-08-21_743b7ff2-f369-4b8c-94a0-5e9658279c85.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

OVERVIEW OF SECOND QUARTER 2019 CONSOLIDATED RESULTS FOR CARASENT ASA (IN NOK AND IFRS).

Revenues of NOK 11,2 million as compared to no NOK 5,8 millon during Q2 -18.

Net income of NOK 0,3 million as compared to net loss of NOK 3,0 million during Q2 -18.

Cash balances of NOK 7,2 million at June 30, 2019.

Evimeria EMR 2Q 2019

  • Revenue of SEK 14,8 million *, an increase of 42 % as compared to Q2 2018
  • EBITDA of SEK 3,4 million as compared to SEK 2,2 million during Q2 2018
  • EBIT of SEK 2,6 million as compared to SEK 1,6 million during Q2 2018
  • * Swedish GAAP and SEK

Revenues

Evimeria EMR 2Q 2019

  • Signed 24 new clinics during the Second Quarter 2019, which is higher than previous year representing more than one new clinic per week
  • Ended the second quarter with 360 active clinics
  • Signed a contract with doktor.se, a leading Swedish online health care provider
  • Occupational health service segment shows good traction and out of the 24 new clinics signed, 4 came from this segment.

Customers

Doktor.se

  • On April 15th Evimeria EMR AB signed a contract with doktor.se, a leading Swedish online-doctor.
  • Important breakthrough with a well-known provider in this fast growing market segment.
  • The contract value is initially approx. SEK 2 million per year and doctor.se will be one of Evimeria biggest customers so far.

Evimeria EMR 2Q 2019

  • The scalability of the business and delivery model continues to increase earnings
  • Well in line with targets for 2019
  • Short- and midterm market conditions seems to remain strong.
  • Long term, Evimeria will accelarate investments to approach new markets and segments 0

EBITDA

Market development and accelerated strategic expansion

The demand for Evimerias services and solutions remains strong

Growth and trends in the healthcare market

Three major drivers

The proportion of the population aged 60 or older

Medical progress and the ability to manage illness are contributing to an overall increased average lifetime

Chronic diseases, such as diabetes, obesity and certain cardiovascular diseases, are increasing and are treated over longer periods of time

The need for high-quality healthcare at lower cost to society has therefore never been greater.

Digitalization is transforming healthcare

The use of digital solutions is increasing availability to patients

Digital solutions also increase opportunities to share necessary and relevant information

Receive healthcare on a remote basis when doctors are available via chat or video,

Strategy going forward

Continue to invest in Evimeria EMR AB and Webdoc and expand in nearby and similar segments

Actively searching to expand geographical and/or service offering through partnerships or acquisitions within the health tech segment

Focus in Scandinavia (Nordics)

Talk to a Data Expert

Have a question? We'll get back to you promptly.